[Biomarkers] SOT - Biomarkers of Disease and Toxicity: Exploiting the Interconnections—2013s

  • Comment 0
  • |
  • Views 4807
  • |
  • By 관리자
  • |
  • Date 2017-01-18
#Biomarker,

SOT (Society of Toxicology) 사이트에 제공되어 있는 강연 자료를 올려드립니다.

출처: http://www.toxicology.org/education/pw/lectures.asp


Biomarkers of Disease and Toxicity: Exploiting the Interconnections—2013

Chairperson(s): Donna L. Mendrick, US FDA, Division of Systems Biology, Jefferson, AR, and William B. Mattes, PharmPoint Consulting, Poolesville, MD.

With the recent focus on (a) cellular pathways involved in toxicity sequelae and (b) translational biomarkers that may link animal and in vitro model observations with clinical reality, there is a need to broaden the understanding of how experimental models may replicate human toxicity and disease processes. Multicellular organisms may have large numbers of genes and proteins, but a relatively limited repertoire in terms of pathophysiology in response to disease or toxicant exposure. This fact allows research to improve and protect human health to be founded on the use of model systems that allow for tractable experimentation. Animal models and, more recently, in vitro systems have served as a means of both exploring mechanisms and identifying hazards in terms of disease and adverse events. However, the interconnections between disease and toxicity are rarely explored leaving the information in silos. This symposium will examine organ-based toxicity and disease processes, and compare lessons learned in biomarker identification and use across toxicity, disease, and species.

 



Introduction

Presenter: Donna L. Mendrick

The usefulness of biomarkers that translate between in vitro/in vivo environments, across species and are shared by disease and toxicity is introduced, with N-acetyltransferase 2 as an example.


 


새로운 글이 작성되었습니다.